Drug intelligence / Profile preview

Fufang Yizhihao

Development stage
Unknown
Lead developer
Xinjiang Yinduolan Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Fufang Yizhihao is a Traditional Chinese Medicine (specifically a Uyghur medicine) developed and manufactured by Xinjiang Yindolan Weiyao Co., Ltd. It is primarily indicated for the treatment of acute upper respiratory tract infections, common cold, fever, and sore throat. The formulation is a compound of several herbal ingredients, typically including *Achillea wilsoniana* (Yizhihao), *Isatis tinctoria* (Banlangen), and *Artemisia rupestris* (Shiyanzhihao). These components work synergistically to provide antipyretic, anti-inflammatory, and antiviral activities. It is commonly administered in granule form and is a staple of ethnomedicine in the Xinjiang region of China, where it is recognized for its efficacy in managing viral and bacterial respiratory ailments.

Brand names
Yindolan
Other names
Compound YizhihaoFufang Yizhihao KeliCompound Achillea Granules
02

Targets

Influenza A virus RNA-directed RNA polymerase complexHMOX1 (Heme oxygenase 1)

Beyond the preview

Go deeper on Fufang Yizhihao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fufang Yizhihao.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call